On March 11 and 12, a group of 3 officials of the Ministry of Nigeria Public Health came to YRPG, making the on-the-spot investigation regarding YRPG's application for pharmaceutical registration and sales.
Accompanied by principals of YRPG Overseas Department and Manufacturing Department, officials visited the high rack warehouse, Quality Inspection Center and several production workshops, detailedly investigating the Company's basic information and timely putting forward opinions and suggestions. Nigeria officials were deeply impressed by YRPG's advanced production lines, convincing quality detection means, and modern management mode. The officials unanimously agreed that YRPG not only have large production scale and beautiful factory, but also pay more attention the quality of products, and concluded that YRPG is a trustworthy partner of Nigeria.
Located in the southeastern part of West Africa, Nigeria is a country with largest population of 140 million in Africa. For a long time, Nigeria is short of doctors and medicine, and backward in medical treatment and facilities, resulting to the wide prevalence of AIDS, malaria, hepatitis, and tuberculosis, etc. It is shown that Nigerian medical market has the prescription drugs capacity of about $1.2 billion per year, and the medicine market is huge because almost all drugs depend on import. The Ministry of Public Health of Nigeria is the main medicine management organization and governs the National Agency for Food and Drug Administration and Control, which is responsible for drug registration and drug quality supervision and control.
It is known that if foreign drugs plan to enter Nigerian market, they must go through the following stages, i.e. sample import, product registration, and product import. At present, in Nigeria, the total of 19 species of YRPG has applied for registration, in which cephalosporins of 3 varieties have been successfully registered. According to convention, inspectors of the Ministry of Nigeria Public Health will carry out the Good Manufacturing Practice (GMP) inspection to the drug manufacturers. Upon receiving the requirement conformity report issued by labs, the Ministry of Public Health will approve product registration and make publicity, then approve the production import and sales. The current investigation of Nigerian health officials laid a foundation for developing African market.